Patrick R. O'Neil, EVP CLO & General Counsel at IONIS PHARMACEUTICALS INC (IONS), sold 3,069 shares at $80.00 ($246K) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Scheduled sale ($246k) by EVP CLO & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2026-01-20 | $697K | — | Filing → |
| IONS | SELL | 2025-10-08 | $1.2M | — | Filing → |
| IONS | SELL | 2025-10-02 | $8.8M | — | Filing → |